These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34105198)

  • 21. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
    Tandon M; Kataria S; Patel J; Mehta TR; Daimee M; Patel V; Prasad A; Chowdhary AA; Jaiswal S; Sriwastava S
    Int J Infect Dis; 2021 Mar; 104():390-397. PubMed ID: 33434662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Finding positive SARS-CoV-2 RT-PCR in cerebrospinal fluid of two pediatric patients with severe COVID-19: a brief case report.
    Sinaei R; Nejadbiglari H; Sinaei R; Zeinaly M; Pezeshki S; Jafari M
    BMC Pediatr; 2023 Jan; 23(1):49. PubMed ID: 36717816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement.
    Alonazi B; Farghaly AM; Mostafa MA; Al-Watban JA; Zindani SA; Altaimi F; Fagiry MA; Mahmoud MZ
    Sci Rep; 2021 Oct; 11(1):20476. PubMed ID: 34650073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.
    Al Saiegh F; Ghosh R; Leibold A; Avery MB; Schmidt RF; Theofanis T; Mouchtouris N; Philipp L; Peiper SC; Wang ZX; Rincon F; Tjoumakaris SI; Jabbour P; Rosenwasser RH; Gooch MR
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):846-848. PubMed ID: 32354770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological complications in COVID-19 - a diagnostic challenge.
    Vacaras V; Frunze S; Cordos AM
    J Med Life; 2021; 14(2):216-224. PubMed ID: 34104245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.
    Domingues RB; Mendes-Correa MC; de Moura Leite FBV; Sabino EC; Salarini DZ; Claro I; Santos DW; de Jesus JG; Ferreira NE; Romano CM; Soares CAS
    J Neurol; 2020 Nov; 267(11):3154-3156. PubMed ID: 32564153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Analysis in Patients With COVID-19.
    Miller EH; Namale VS; Kim C; Dugue R; Waldrop G; Ciryam P; Chong AM; Zucker J; Miller EC; Bain JM; Willey JZ; Doyle K; Boehme A; Claassen J; Uhlemann AC; Thakur KT
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa501. PubMed ID: 33230485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review.
    Fadakar N; Ghaemmaghami S; Masoompour SM; Shirazi Yeganeh B; Akbari A; Hooshmandi S; Ostovan VR
    Cerebellum; 2020 Dec; 19(6):911-914. PubMed ID: 32737799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-tier stratification for CNS COVID-19 to help decide which patients should undergo lumbar puncture with CSF analysis: a case report and literature review.
    Ramakrishna JM; Libertin CR; Siegel J; Binnicker MJ; Harris D; Matcha GV; Caulfield T; Freeman WD
    Rom J Intern Med; 2021 Mar; 59(1):88-92. PubMed ID: 33098636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.
    Devlin L; Gombolay GY
    J Neurol; 2023 Nov; 270(11):5155-5161. PubMed ID: 37581633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
    Lebrun L; Absil L; Remmelink M; De Mendonça R; D'Haene N; Gaspard N; Rusu S; Racu ML; Collin A; Allard J; Zindy E; Schiavo AA; De Clercq S; De Witte O; Decaestecker C; Lopes MB; Salmon I
    Acta Neuropathol Commun; 2023 May; 11(1):78. PubMed ID: 37165453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
    Kanberg N; Grahn A; Stentoft E; Bremell D; Yilmaz A; Studahl M; Nilsson S; Schöll M; Gostner JM; Blennow K; Zetterberg H; Padmanabhan N; Cohen R; Misaghian S; Romero D; Campbell C; Mathew A; Wang M; Sigal G; Stengelin M; Edén A; Gisslén M
    J Infect Dis; 2024 Feb; 229(2):493-501. PubMed ID: 37874918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic.
    Huo L; Xu KL; Wang H
    World J Clin Cases; 2021 Feb; 9(5):1058-1078. PubMed ID: 33644169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
    Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
    J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute-onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro-pollutants.
    Schneider F; Agin A; Baldacini M; Maurer L; Schenck M; Alemann M; Solis M; Helms J; Villette C; Artzner T; Kremer S; Heintz D
    Eur J Neurol; 2021 Oct; 28(10):3443-3447. PubMed ID: 33583103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.